Crossmark

Low SP1 SUMOylation-dependent SNHG17 upregulation promotes drug resistance of gastric cancer through impairing hsa-miR-23b-3p-induced Notch2 inhibition

Crossref DOI link: https://doi.org/10.1007/s13402-022-00722-4

Published Online: 2022-10-10

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huang, Guoyu

Cai, Guohao

Hu, Dongwei

Li, Jinjie

Xu, Qigang

Chen, Zongjing

Xu, Bo
Funding

Funding for this research was provided by:

Zhejiang Province Hepatobiliary and Pancreatic Diseases Clinical Medical Research Center (193)
License Information

Text and Data Mining valid from 2022-10-10

Version of Record valid from 2022-10-10
More Information

Article History

Accepted: 13 September 2022

First Online: 10 October 2022

Declarations

:

: Not applicable.

: I represent all my co-authors who have approved the publication of the article.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below